The Form 4 filing, a report of an insider's stock trades, was filed on November 10, 2026. The purchases took place from November 6 through November 10. Carl L. Gordon is listed as a director and 10% owner of Electra Therapeutics.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-06 |
| Date of Latest Transaction | 2026-11-10 |
| Buy/Sell | buy |
| Transaction Count | 6 |
| Shares Transacted | 92,116 |
| Price | $8.08 |
| Total Transaction Value | $744,530.60 |
| Insider | |
| Ticker Symbol | ETRA |
| Company | Electra Therapeutics, Inc. |
| Insider Name | GORDON CARL L |
| Insider Title | Director, 10% Owner |
| Sector - Industry | Other - Unclassified |
| Holdings | |
| Total Shares Owned After Transaction | 5,255,278 |
| Position Size Change | 1.75% |
| Filing | |
| Filing Date | 2026-11-10 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
These were purchases of ETRA shares, reported with transaction code P. The six transactions are grouped in one filing for one insider. Separate share counts for each purchase were not provided.
What was the average price of the transaction?
The average purchase price was $8.08 per share, rounded to the nearest cent. This average covers all six purchases. The price paid in each separate trade was not provided.
How did this transaction affect the insider's holdings?
The purchases added 92,116 shares to Carl L. Gordon's reported holdings. He reported owning 5,255,278 shares afterward. The shares bought made up 1.75% of the shares he owned after the purchases.
What's the total transaction value?
The total reported value was $744,530.60. That amount covers all six purchases from November 6 through November 10, 2026.
Are there any special circumstances around this transaction?
The available transaction information did not identify a special arrangement. Filing footnote text was not available, so further details about how the purchases were arranged remain unknown.
For research purposes only; not investment advice.